111 related articles for article (PubMed ID: 24814966)
1. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
[TBL] [Abstract][Full Text] [Related]
3. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
[TBL] [Abstract][Full Text] [Related]
5. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
7. In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong.
Chen JH; Wong KH; Li PC; Chan KK; Lee MP; To SW; Yam WC
Hong Kong Med J; 2012 Feb; 18(1):20-4. PubMed ID: 22302906
[TBL] [Abstract][Full Text] [Related]
8. Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.
Budayanti NS; Merati TP; Bela B; Mahardika GN
Curr HIV Res; 2018; 16(5):374-382. PubMed ID: 30714528
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
[TBL] [Abstract][Full Text] [Related]
10. Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia.
Indriati DW; Kotaki T; Khairunisa SQ; Witaningrum AM; Matondang MQY; Ueda S; Nasronudin ; Purnama A; Kurniawan D; Kameoka M
Curr HIV Res; 2018; 16(2):158-166. PubMed ID: 29732988
[TBL] [Abstract][Full Text] [Related]
11. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
[TBL] [Abstract][Full Text] [Related]
13. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011.
Guo H; Xu X; Hu H; Zhou Y; Yang H; Qiu T; Fu G; Huan X
BMC Public Health; 2015 Feb; 15():120. PubMed ID: 25879488
[TBL] [Abstract][Full Text] [Related]
15. Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.
Ammaranond P; Sanguansittianant S; Raju PA; Cunningham P; Horthongkham N
J Virol Methods; 2014 Apr; 199():102-7. PubMed ID: 24462843
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
[TBL] [Abstract][Full Text] [Related]
17. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.
Fokam J; Salpini R; Santoro MM; Cento V; D'Arrigo R; Gori C; Perno CF; Colizzi V; Nanfack A; Gwom LC; Cappelli G; Takou D
Arch Virol; 2011 Jul; 156(7):1235-43. PubMed ID: 21465085
[TBL] [Abstract][Full Text] [Related]
19. The biological characteristics of predominant strains of HIV-1 genotype: modeling of HIV-1 infection among men who have sex with men.
Dai D; Shang H; Han XX; Zhao B; Liu J; Ding HB; Xu JJ; Chu ZX
J Med Virol; 2015 Apr; 87(4):557-68. PubMed ID: 25655808
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
